Atezolizumab in advanced hepatocellular carcinoma: good things come to those who wait

A Rizzo, AD Ricci, G Brandi - Immunotherapy, 2021 - Taylor & Francis
Advanced hepatocellular carcinoma (HCC) patients present poor prognosis. However,
recent years have seen the advent of several novel treatments in this setting, where the role …
被引用次数：74 相关文章

Atezolizumab in advanced hepatocellular carcinoma: good things come to those who wait

A Rizzo, AD Ricci, G Brandi - Immunotherapy, 2021 - pubmed.ncbi.nlm.nih.gov
Advanced hepatocellular carcinoma (HCC) patients present poor prognosis. However,
recent years have seen the advent of several novel treatments in this setting, where the role …

Atezolizumab in advanced hepatocellular carcinoma: Good things come to those who wait

A Rizzo, AD Ricci, G Brandi - IMMUNOTHERAPY, 2021 - cris.unibo.it
Advanced hepatocellular carcinoma (HCC) patients present poor prognosis. However,
recent years have seen the advent of several novel treatments in this setting, where the role …

Atezolizumab in advanced hepatocellular carcinoma: good things come to those who wait.

A Rizzo, AD Ricci, G Brandi - Immunotherapy, 2021 - europepmc.org
Advanced hepatocellular carcinoma (HCC) patients present poor prognosis. However,
recent years have seen the advent of several novel treatments in this setting, where the role …